Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparative study of BK1601 versus MR vaccine in Japanese children
jRCT2080225149Phase 3Completed
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of BK1601 in measles and rubella (2 arms), sponsored by Research Foundation for Microbial Diseases of Osaka University. Started Apr 2020; status: completed.
02
Drugs
BK1601
03
Conditions
measlesrubella
Beyond the preview
Go deeper on jRCT2080225149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225149.